Birdwatch Note Rating
2024-05-19 03:34:39 UTC - HELPFUL
Rated by Participant: E5CC519AAB4D7FF06DB91AE2CB3AB8A9C07DF62A89A232784B3CE18D75916334
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 50% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://nejm.org/doi/full/10.1056/nejmoa1910993 https://paho.org/en/topics/ebola-virus-disease
All Note Details